“On October 6, 2023, the Drug Enforcement Administration (DEA) released a second temporary rule extending the COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,” Nathan Beaver and Thomas Ferrante of Foley & Lardner write over at National Law Review. “This second extension, issued shortly after DEA’s listening session on a potential new Telemedicine Special Registration, gives practitioners and […]
